Make smart decisions about your research projects.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

Neurological diseases develop out of sight. Novartis neuroscientists are bringing them into the light, using human brain cells grown in the lab.

Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.

Targeting inflammation to fight cancer is a new approach with a long history.

Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.

A Q&A with Bryan Laffitte, who leads a Novartis team that’s using the tools of genetic medicine to innovate new therapies for neuromuscular and neurodegenerative conditions.